@article{ref1,
title="Emergency department based intervention with adolescent substance users: 10 year economic and health outcomes",
journal="Drug and alcohol dependence",
year="2016",
author="Tait, Robert J. and Teoh, Lucinda and Kelty, Erin and Geelhoed, Elizabeth and Mountain, David and Hulse, Gary K.",
volume="165",
number="",
pages="168-174",
abstract="BACKGROUND: Alcohol and other drug (AOD) use are significant cause of disease burden and costs among adolescents. <br><br>METHODS: We conducted a randomized trial in hospital emergency departments (ED) following an AOD-related presentation, comparing usual care with brief advice and referral to link adolescents aged 12-19 years with external AOD services. Subsequently, we used health data linkage to assemble data on mortality, hospital admissions, ED attendances, out-patient mental health and use of opiate pharmacotherapies in the next 10 years. From these, treatment costs and rates of events were estimated and compared using generalized linear models. <br><br>RESULTS: Those who received the intervention had lower costs ($22 versus $227: z=3.16, p=0.002) and rates (0.03 versus 0.25: z=2.57, p=0.010) of ED mental health AOD presentations. However, the intervention did not significantly reduce overall mean health costs per patient (intervention $58746 versus control $64833, p=0.800). Similarly, there was no significant difference in the costs associated with hospitalizations ($48920 versus $50911 p=0.924), overall ED presentations ($4266 versus $4150, p=0.916), out-patient mental health services ($4494 versus $7717, p=0.282), or opiate pharmacotherapies ($1013 versus $2054, p=0.209). Injecting drug use was a significant baseline predictor of subsequent costs in the cohort (z=2.64, p=0.008). <br><br>CONCLUSIONS: An ED delivered intervention may reduce direct ED costs and subsequent ED AOD attendances. There was also some indication that overall costs may be impacted, with economically large but non-significant differences between the groups. The high costs and morbidity incurred by some of this cohort illustrate the importance of targeting high-risk adolescents.<br><br>Copyright © 2016. Published by Elsevier Ireland Ltd.<p /> <p>Language: en</p>",
language="en",
issn="0376-8716",
doi="10.1016/j.drugalcdep.2016.06.005",
url="http://dx.doi.org/10.1016/j.drugalcdep.2016.06.005"
}